CTLT vs MRSN
CTLT (CTLT) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
CTLT (CTLT) common stock.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
CTLT does not have a complete income-statement cache yet.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
MRSN currently screens at market cap $145.4M.
Not investment advice. Open the CTLT and MRSN stock pages for the full models.
Not investment advice.